Xiaolong Cao

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Pharmacovigilance analysis of immune checkpoint inhibitor-associated optic nerve toxicity based on the FAERS database.

Pharmacovigilance analysis of immune checkpoint inhibitor-associated optic nerve toxicity based on the FAERS database.

Journal: Frontiers in pharmacology
Published: April 02, 2026

Case Report: A successful rechallenge with aumolertinib after osimertinib-induced severe interstitial lung disease.

Case Report: A successful rechallenge with aumolertinib after osimertinib-induced severe interstitial lung disease.

Journal: Frontiers in pharmacology
Published: January 12, 2026

SPP1+ macrophage-driven interactions shape the tumor microenvironment in lymph node metastatic acral melanoma.

SPP1+ macrophage-driven interactions shape the tumor microenvironment in lymph node metastatic acral melanoma.

Journal: Cell death & disease
Published: September 17, 2025

Multi-Omics Reveal the Dysregulated Gut-Joint Axis in Knee Synovitis: Data from Two Osteoarthritis Studies in China.

Multi-Omics Reveal the Dysregulated Gut-Joint Axis in Knee Synovitis: Data from Two Osteoarthritis Studies in China.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 30, 2025

Case Report: Subacute cutaneous lupus erythematosus induced by the anti-PD-1 antibody camrelizumab combined with chemotherapy.

Case Report: Subacute cutaneous lupus erythematosus induced by the anti-PD-1 antibody camrelizumab combined with chemotherapy.

Journal: Frontiers in immunology
Published: December 04, 2024

A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer.

A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer.

Journal: Journal of cancer research and clinical oncology
Published: November 15, 2024

Intrahepatic cholangiocarcinoma patient with epidermal growth factor receptor exon 19 deletion unresponsive to Afatinib monotherapy: a case report.

Intrahepatic cholangiocarcinoma patient with epidermal growth factor receptor exon 19 deletion unresponsive to Afatinib monotherapy: a case report.

Journal: Discover oncology
Published: October 21, 2024

Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression.

Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression.

Journal: Frontiers in pharmacology
Published: June 13, 2024

Radical chemoradiotherapy for superficial esophageal cancer complicated with liver cirrhosis.

Radical chemoradiotherapy for superficial esophageal cancer complicated with liver cirrhosis.

Journal: PeerJ
Published: April 17, 2024

Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAFV600E-associated thyroid carcinoma.

Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAFV600E-associated thyroid carcinoma.

Journal: Clinical and translational medicine
Published: November 29, 2023

The Effects of Drug Exposure and Single Nucleotide Polymorphisms on Aaptinib-Induced Severe Toxicities in Solid Tumors.

The Effects of Drug Exposure and Single Nucleotide Polymorphisms on Aaptinib-Induced Severe Toxicities in Solid Tumors.

Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: June 20, 2023

Raddeanin A Improves the Therapeutic Effect of Osimertinib in NSCLC by Accelerating ROS/NLRP3-mediated Pyroptosis.

Raddeanin A Improves the Therapeutic Effect of Osimertinib in NSCLC by Accelerating ROS/NLRP3-mediated Pyroptosis.

Journal: Current pharmaceutical design
Published: May 19, 2023
Showing 1-12 of 35

Last Updated: 09/26/2026